In gastric carcinomas, MK-1 is more frequently expressed in cardiac tumors (with 50% expression rate), in large (> 3 cm) tumors, and in specimens from patients with more than five metastatic lymph nodes [2]. Here, EPCAM is linked to heart neoplasm.